336 related articles for article (PubMed ID: 29128232)
1. Liposome-based immunity-inducing systems for cancer immunotherapy.
Yuba E
Mol Immunol; 2018 Jun; 98():8-12. PubMed ID: 29128232
[TBL] [Abstract][Full Text] [Related]
2. Preparation of glycopeptide-modified pH-sensitive liposomes for promoting antigen cross-presentation and induction of antigen-specific cellular immunity.
Yuba E; Gupta RK
Biomater Sci; 2024 Mar; 12(6):1490-1501. PubMed ID: 38329387
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA.
Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
Biomaterials; 2017 Oct; 141():272-283. PubMed ID: 28704679
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.
Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
Biomaterials; 2014 Sep; 35(28):8186-96. PubMed ID: 24969637
[TBL] [Abstract][Full Text] [Related]
5. pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-γ gene lipoplex for efficient cancer immunotherapy.
Yuba E; Kanda Y; Yoshizaki Y; Teranishi R; Harada A; Sugiura K; Izawa T; Yamate J; Sakaguchi N; Koiwai K; Kono K
Biomaterials; 2015 Oct; 67():214-24. PubMed ID: 26222284
[TBL] [Abstract][Full Text] [Related]
6. Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity.
Chiang CY; Chen YJ; Wu CC; Liu SJ; Leng CH; Chen HW
Front Immunol; 2018; 9():822. PubMed ID: 29755461
[TBL] [Abstract][Full Text] [Related]
7. pH-Sensitive branched β-glucan-modified liposomes for activation of antigen presenting cells and induction of antitumor immunity.
Yanagihara S; Kasho N; Sasaki K; Shironaka N; Kitayama Y; Yuba E; Harada A
J Mater Chem B; 2021 Sep; 9(37):7713-7724. PubMed ID: 34545900
[TBL] [Abstract][Full Text] [Related]
8. Bioactive polysaccharide-based pH-sensitive polymers for cytoplasmic delivery of antigen and activation of antigen-specific immunity.
Yuba E; Yamaguchi A; Yoshizaki Y; Harada A; Kono K
Biomaterials; 2017 Mar; 120():32-45. PubMed ID: 28027502
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity.
Kawamura K; Kadowaki N; Suzuki R; Udagawa S; Kasaoka S; Utoguchi N; Kitawaki T; Sugimoto N; Okada N; Maruyama K; Uchiyama T
J Immunother; 2006; 29(2):165-74. PubMed ID: 16531817
[TBL] [Abstract][Full Text] [Related]
10. Cationic lipid potentiated the adjuvanticity of polysaccharide derivative-modified liposome vaccines.
Yuba E; Kado Y; Kasho N; Harada A
J Control Release; 2023 Oct; 362():767-776. PubMed ID: 36244508
[TBL] [Abstract][Full Text] [Related]
11. Coupled for cross-presentation in tumor immunotherapy.
Pang B; Neefjes J
Sci Transl Med; 2010 Aug; 2(44):44ps40. PubMed ID: 20702855
[TBL] [Abstract][Full Text] [Related]
12. Nanoengineered Immune Niches for Reprogramming the Immunosuppressive Tumor Microenvironment and Enhancing Cancer Immunotherapy.
Phuengkham H; Ren L; Shin IW; Lim YT
Adv Mater; 2019 Aug; 31(34):e1803322. PubMed ID: 30773696
[TBL] [Abstract][Full Text] [Related]
13. Drug Delivery for Cancer Immunotherapy and Vaccines.
Batty CJ; Tiet P; Bachelder EM; Ainslie KM
Pharm Nanotechnol; 2018; 6(4):232-244. PubMed ID: 30227827
[TBL] [Abstract][Full Text] [Related]
14. Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity
van den Bijgaart RJE; Schuurmans F; Fütterer JJ; Verheij M; Cornelissen LAM; Adema GJ
Front Immunol; 2021; 12():617365. PubMed ID: 33936033
[No Abstract] [Full Text] [Related]
15. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
[TBL] [Abstract][Full Text] [Related]
16. Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy.
Yuba E; Tajima N; Yoshizaki Y; Harada A; Hayashi H; Kono K
Biomaterials; 2014 Mar; 35(9):3091-101. PubMed ID: 24406217
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cells and Cancer Immunity.
Gardner A; Ruffell B
Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
[TBL] [Abstract][Full Text] [Related]
18. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
Sheen MR; Fiering S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
[TBL] [Abstract][Full Text] [Related]
19. Development of pH-Responsive Hyaluronic Acid-Based Antigen Carriers for Induction of Antigen-Specific Cellular Immune Responses.
Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K
ACS Biomater Sci Eng; 2019 Nov; 5(11):5790-5797. PubMed ID: 33405671
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin Sulfate-Based pH-Sensitive Polymer-Modified Liposomes for Intracellular Antigen Delivery and Induction of Cancer Immunity.
Okubo M; Miyazaki M; Yuba E; Harada A
Bioconjug Chem; 2019 May; 30(5):1518-1529. PubMed ID: 30945847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
